Modulation of macrophage differentiation and activation by decoy receptor 3

Journal of Leukocyte Biology

Volumn 75, Issue 3, 2004, Pages 486-494

  Chang, Yung Chi ^a   Hsu, Tsui Ling ^a   Lin, Hsi Hsien ^b   Chio, Chung Ching ^c   Chiu, Allen W ^c   Chen, Nien Jung ^a   Lin, Chi Hung ^a   Hsieh, Shie Liang ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Apoptosis; Inflammation; Phagocytosis; Tumor necrosis factor

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD36 ANTIGEN; CD64 ANTIGEN; CD68 ANTIGEN; COLONY STIMULATING FACTOR 1; DECOY RECEPTOR 3; FREE RADICAL; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN; LIPOPOLYSACCHARIDE; MANNOSE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DOWN REGULATION; FLOW CYTOMETRY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IN VITRO STUDY; MACROPHAGE ACTIVATION; MODULATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD; ANTIGENS, CD14; CELL DIFFERENTIATION; DRUG INTERACTIONS; FREE RADICALS; HUMANS; JURKAT CELLS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MONOCYTES; PHAGOCYTOSIS; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; RECOMBINANT FUSION PROTEINS;

EID: 1542283729     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0903448     Document Type: Article

References (32)

1. Pitti, R. M., Marsters, S. A., Lawrence, D. A., Roy, M., Kischkel, F. C., Dowd, P., Huang, A., Donahue, C. J., Sherwood, S. W., Baldwin, D. T., Godowski, P. J., Wood, W. I., Gurney, A. L., Hillan, K. J., Cohen, R. L., Goddard, A. D., Botstein, D., Ashkenazi, A. (1998) Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396, 699-703.
2. Yu, K. Y., Kwon, B., Ni, J., Zhai, Y., Ebner, R., Kwon, B. S. (1999) A newly identified member of tumor necrosis factor receptor superfamily TR6) suppresses LIGHT-mediated apoptosis. J. Biol. Chem. 274, 13733-13736.
3. Migone, T. S., Zhang, J., Luo, X., Zhuang, L., Chen, C., Hu, B., Hong, J. S., Perry, J. W., Chen, S. F., Zhou, J. X., Cho, Y. H., Ullrich, S., Kanakaraj, P., Carrell, J., Boyd, E., Olsen, H. S., Hu, G., Pukac, L., Liu, D., Ni, J., Kim, S., Gentz, R., Feng, P., Moore, P. A., Ruben, S. M., Wei, P. (2002) TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16, 479-492.
4. Bai, C., Connolly, B., Metzker, M. L., Hilliard, C. A., Liu, X., Sandig, V., Soderman, A., Galloway, S. M., Liu, Q., Austin, C. P., Caskey, C. T. (2000) Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc. Natl. Acad. Sci. USA 97, 1230-1235.
5. Takahama, Y., Yamada, Y., Emoto, K., Fujimoto, H., Takayama, T., Ueno, M., Uchida, H., Hirao, S., Mizuno, T., Nakajima, Y. (2002) The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas. Gastric Cancer 5, 61-68.
6. Ohshima, K., Haraoka, S., Sugihara, M., Suzumiya, J., Kawasaki, C., Kanda, M., Kikuchi, M., Sheikh, M. S., Fornace Jr., A. J. (2000) Amplification and expression of a decoy receptor for Fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas Death and decoy receptors and p53-mediated apoptosis. Cancer Lett. 160, 89-97.
7. Roth, W., Isenmann, S., Nakamura, M., Platten, M., Wick, W., Kleihues, P., Bahr, M., Ohgaki, H., Ashkenazi, A., Weller, M. (2001) Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res. 61, 2759-2765.
8. Hsu, T. L., Chang, Y. C., Chen, S. J., Liu, Y. J., Chiu, A. W., Chio, C. C., Chen, L., Hsieh, S. L. (2002) Modulation of dendritic cell differentiation and maturation by decoy receptor 3. J. Immunol. 168, 4846-4853.
9. Morrissette, N., Gold, E., Aderem, A. (1999) The macrophage-a cell for all seasons. Trends Cell Biol. 9, 199-201.
10. Medzhitov, R., Janeway Jr., C. (2000) Innate immunity. N. Engl. J. Med. 343, 338-344.
11. Aderem, A., Underhill, D. M. (1999) Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17, 593-623.
12. Anderson, K. V. (2000) Toll signaling pathways in the innate immune response. Curr. Opin. Immunol. 12, 13-19.
13. Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., Henson, P. M. (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J. Clin. Invest. 101, 890-898.
14. Engleman, E. G., Benike, C. J., Hoppe, R. T., Kaplan, H. S., Berberich, F. R. (1980) Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect. J. Clin. Invest. 66, 149-158.
15. Nakata, Y., Yamashita, J., Kishi, T., Kataoka, M., Ejiri, T., Ohnoshi, T., Kimura, I. (1985) Decreased monocyte-mediated cytostasis of human cancer cell in patients with lung cancer. Cancer Immunol. Immunother. 20, 43-46.
16. Elgert, K. D., Alleva, D. G., Mullins, D. W. (1998) Tumor-induced immune dysfunction: the macrophage connection. J. Leukoc. Biol. 64, 275-290.
17. Siziopikou, K. P., Harris, J. E., Casey, L., Nawas, Y., Braun, D. P. (1991) Impaired tumoricidal function of alveolar macrophages from patients with non-small cell lung cancer. Cancer 68, 1035-1044.
18. Bernasconi, S., Matteucci, C., Sironi, M., Conni, M., Colotta, F., Mosca, M., Colombo, N., Bonazzi, C., Landoni, F., Corbetta, G., et al. (1995) Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages. Int. J. Cancer 60, 300-307.
19. Ettingel, R., Browning, J. L., Michie, S. A., van Ewijk, W., McDevitt, H. O. (1996) Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-β receptor-IgG1 fusion protein. Proc. Natl. Acad. Sci. USA 93, 13102-13107.
20. Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P., Amigorena, S. (1999) Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1, 362-368.
21. Butcher, E. C., Weissman, I. L. (1980) Direct fluorescent labeling of cells with fluorescein or rhodamine isothiocyanate. I. Technical aspects. J. Immunol. Methods 37, 97-108.
22. Hess, K. L., Babcock, G. F., Askew, D. S., Cook-Mills, J. M. (1997) A novel flow cytometric method for quantifying phagocytosis of apoptotic cells. Cytometry 27; 145-152.
23. Daeron, M. (1997) Fc receptor biology. Annu. Rev. Immunol. 15, 203-234.
24. Fadok, V. A., Bratton, D. L., Frasch, S. C., Warner, M. L., Henson, P. M. (1998) The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 5, 551-562.
25. Savill, J., Fadok, V. (2000) Corpse clearance defines the meaning of cell death. Nature 407, 784-788.
26. Haziot, A., Ferrero, E., Kontgen, F., Hijiya, N., Yamamoto, S., Silver, J., Stewart, C. L., Goyert, S. M. (1996) Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4, 407-414.
27. Hamilton, J. A. (1997) CSF-1 signal transduction. J. Leukoc. Biol. 62, 145-155.
28. Bourette, R. P., Rohrschneider, L. R. (2000) Early events in M-CSF receptor signaling. Growth Factors 17, 155-166.
29. Hume, D. A., Yue, X., Ross, I. L., Favot, P., Lichanska, A., Ostrowski, M. C. (1997) Regulation of CSF-1 receptor expression. Mol. Reprod. Dev. 46, 46-52.
30. Valledor, A. F., Borras, F. E., Cullell-Young, M., Celada, A. (1998) Transcription factors that regulate monocyte/macrophage differentiation. J. Leukoc. Biol. 63, 405-417.
31. DiGabriele, A. D., Lax, I., Chen, D. I., Svahn, C. M., Jaye, M., Schlessinger, J., Hendrickson, W. A. (1998) Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature 393, 812-817.
32. Sasisekharan, R., Shriver, Z., Venkataraman, G., Narayanasami, U. (2002) Roles of heparan-sulphate glycosaminoglycans in cancer. Nat. Rev. Cancer 2, 521-528.